The Discounted Cash Flow (DCF) valuation of AtriCure Inc (ATRC) is (20.11) USD. With the latest stock price at 35.96 USD, the upside of AtriCure Inc based on DCF is -155.9%.
Based on the latest price of 35.96 USD and our DCF valuation, AtriCure Inc (ATRC) is a sell. selling AtriCure stocks now will result in a potential gain of 155.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 10.2% | 8.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (73.34) - (11.81) | (20.11) |
| Upside | -303.9% - -132.9% | -155.9% |